Dr. John I. Delgado, MD

Dr. Delgado practices at HCA Florida South Tampa Hospital in Tampa, Florida, part of HCA Healthcare.

Dr. Delgado's NPI, 1366460958, was assigned on July 18, 2006. Dr. Delgado graduated from University of Illinois College of Medicine - Chicago in 1985. Dr. Delgado holds Florida license ME54871.

Dr. Delgado's primary practice is HCA Florida South Tampa Hospital, at 2901 W Swann Ave, Tampa, FL 33609 in Hillsborough County. The practice phone is (813) 873-6400.

Dr. Delgado's primary practice is HCA Florida South Tampa Hospital in Tampa, Florida, part of HCA Healthcare. Dr. Delgado is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Florida Digestive Health Specialists. Dmand AI also links Dr. Delgado to 1 more hospital, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delgado practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Delgado's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Delgado's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Delgado treats.

CMS data shows 1,231 Medicare services from Dr. Delgado across 13 procedure codes in 2024, for 211 Medicare patients. Medicare paid $103,447 for them.

CMS counts 211 Medicare patients who saw Dr. Delgado in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delgado's median patient age at 65, with 57% women.

In 2024, Dr. Delgado wrote 460 Medicare Part D claims for 196 patients. 83% of them were for generic drugs. CMS names the drug for 375 of them, across 9 drugs with 11 or more claims each, at $80,640 in total drug cost. In 2023, CMS named 334 claims across 12 drugs.

Dr. Delgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 194 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Delgado, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 113 general payments to Dr. Delgado from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Abbvie Inc. paid the most, $833. It also lists 5 research payments totaling $20,596 in 2023.

Dr. Delgado graduated from University of Illinois College of Medicine - Chicago in 1985.

Dr. Delgado is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.